Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells

ISSN: 0026895X
348Citations
Citations of this article
100Readers
Mendeley users who have this article in their library.

Abstract

Anandamide (arachidonyl ethanolamide) has been identified as an endogenous ligand of cannabinoid receptors on the basis of its ability to displace 3H-labeled synthetic cannabinoid in a binding assay. One well characterized cellular action of cannabinoids is inhibition of hormonally stimulated adenylyl cyclase. Another action of synthetic cannabinoids is potent, stereospecific, and reversible inhibition of N-type calcium currents (lca) in the NG108-15 neuroblastoma-glioma cell line via a pertussis toxin (PTX)-sensitive pathway, independently of cAMP metabolism. Here we used the N18 neuroblastoma cell line and the whole-cell voltageclamp technique to show that anandamide also potently inhibits N-type lCa in a PTX-sensitive fashion. As with the cannabinomimetic aminoalkylindole WIN 55,212-2, inhibition by anandamide was voltage dependent and N-ethylmaleimide sensitive. However, anandamide was less efficacious than either WIN 55,212-2 or the nonclassical cannabinoid CP 55,940. Indeed, anandamide appears to act as a partial agonist at the cannabinoid receptor. Application of WIN 55,212-2 always caused further inhibition of lea in cells exposed to a maximally effective concentration of anandamide, and application of anandamide always caused a partial recovery of lCa in cells exposed to a maximally effective concentration of WIN 55,212-2. This partial agonist property of anandamide suggests that, although anandamide inhibits N-type lCa via a PTX-sensitive G protein, its actions as a neuromodulator in the intact animal may be more complex than would be inferred by extrapolating the results of in vivo studies with (-)-Δ9-tetrahydrocannabinol or synthetic cannabinoids.

References Powered by Scopus

Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

15820Citations
N/AReaders
Get full text

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

4974Citations
N/AReaders
Get full text

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

4459Citations
N/AReaders
Get full text

Cited by Powered by Scopus

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

2514Citations
N/AReaders
Get full text

The endocannabinoid system as an emerging target of pharmacotherapy

1790Citations
N/AReaders
Get full text

Pharmacology of cannabinoid CB<inf>1</inf> and CB<inf>2</inf> receptors

1375Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Mackie, K., Devane, W. A., & Hille, B. (1993). Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Molecular Pharmacology, 44(3), 498–503.

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 34

54%

Researcher 17

27%

Professor / Associate Prof. 12

19%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 25

42%

Neuroscience 14

23%

Medicine and Dentistry 12

20%

Pharmacology, Toxicology and Pharmaceut... 9

15%

Save time finding and organizing research with Mendeley

Sign up for free